JP2024541315A5 - - Google Patents

Info

Publication number
JP2024541315A5
JP2024541315A5 JP2024527312A JP2024527312A JP2024541315A5 JP 2024541315 A5 JP2024541315 A5 JP 2024541315A5 JP 2024527312 A JP2024527312 A JP 2024527312A JP 2024527312 A JP2024527312 A JP 2024527312A JP 2024541315 A5 JP2024541315 A5 JP 2024541315A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
pharmaceutically acceptable
acceptable salt
nri
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024527312A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024541315A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/049483 external-priority patent/WO2023086433A1/en
Publication of JP2024541315A publication Critical patent/JP2024541315A/ja
Publication of JP2024541315A5 publication Critical patent/JP2024541315A5/ja
Pending legal-status Critical Current

Links

JP2024527312A 2021-11-11 2022-11-10 中枢性低換気に関連する状態を治療するための方法および組成物 Pending JP2024541315A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163278324P 2021-11-11 2021-11-11
US63/278,324 2021-11-11
US202263305305P 2022-02-01 2022-02-01
US63/305,305 2022-02-01
PCT/US2022/049483 WO2023086433A1 (en) 2021-11-11 2022-11-10 Methods and compositions for treating conditions associated with central hypoventilation

Publications (2)

Publication Number Publication Date
JP2024541315A JP2024541315A (ja) 2024-11-08
JP2024541315A5 true JP2024541315A5 (cg-RX-API-DMAC7.html) 2025-11-17

Family

ID=84627454

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024527312A Pending JP2024541315A (ja) 2021-11-11 2022-11-10 中枢性低換気に関連する状態を治療するための方法および組成物

Country Status (9)

Country Link
US (1) US20250000823A1 (cg-RX-API-DMAC7.html)
EP (1) EP4429649A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024541315A (cg-RX-API-DMAC7.html)
KR (1) KR20240108453A (cg-RX-API-DMAC7.html)
AU (1) AU2022387440A1 (cg-RX-API-DMAC7.html)
CA (1) CA3237151A1 (cg-RX-API-DMAC7.html)
IL (1) IL312688A (cg-RX-API-DMAC7.html)
MX (1) MX2024005600A (cg-RX-API-DMAC7.html)
WO (1) WO2023086433A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025207125A1 (en) * 2024-03-26 2025-10-02 The Regents Of The University Of California Combination pharmacological interventions for obstructive sleep apnea

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
EP3685858A1 (en) * 2019-01-24 2020-07-29 Assistance Publique-Hopitaux De Paris A noradrenergic system stimulator in the treatment of central hypoventilation syndromes
US20220362221A1 (en) * 2019-11-04 2022-11-17 Apnimed, Inc. (Delaware) Combination pharmacological interventions for multiple mechanisms of obstructive sleep apnea

Similar Documents

Publication Publication Date Title
ES2378255T3 (es) Titulación de tapentadol
US10881657B2 (en) Bupropion as a modulator of drug activity
ES2304041T3 (es) Nuevos tratamientos que utilizan derivados de fenetilamina.
US10092561B2 (en) Compositions and methods comprising bupropion or related compounds for sustained delivery of dextromethorphan
US10058518B2 (en) Bupropion as a modulator of drug activity
US10105327B2 (en) Compositions and methods for increasing the metabolic lifetime of dextromethorphane and related pharmacodynamic effects
US20200022929A1 (en) Bupropion as a modulator of drug activity
TWI312285B (en) Methods of treatment using a gastric retained gabapentin dosage
US9700553B2 (en) Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
US20190192507A1 (en) Bupropion as a modulator of drug activity
US20190142768A1 (en) Bupropion as a modulator of drug activity
US20200129474A1 (en) Combination therapy for effecting weight loss and treating obesity
US20170304298A1 (en) Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
KR20090090316A (ko) 체중 감량 약물을 투여하기 위한 단위 용량 팩키지 및 투여 방법
US20160317476A1 (en) Compositions and Methods for Increasing the Metabolic Lifetime of Dextromethorphan and Related Pharmacodynamic Effects
US20220211678A1 (en) Uses of (+)-a-dihydrotetrabenazine in methods of treating movement disorder
JP2025084754A5 (cg-RX-API-DMAC7.html)
JP2007533733A (ja) 食物摂取管理の方法
JP2022519721A5 (cg-RX-API-DMAC7.html)
JP2025508406A5 (cg-RX-API-DMAC7.html)
CA2485736A1 (en) Methods of treating gastrointestinal and genitourinary pain disorders using venlafaxine and derivatives
JP2020533415A (ja) ナルコレプシーの処置におけるガボキサドールの使用
TW200835477A (en) Methods for treating depression
EP2089022A2 (en) Composition containing a mixture of antidepressants for treating premature ejaculation
CN114786668B (zh) 用于治疗抑郁症的环丝氨酸和锂的组合疗法